Normala Abd Latip

649 total citations
19 papers, 468 citations indexed

About

Normala Abd Latip is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Normala Abd Latip has authored 19 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Computational Theory and Mathematics. Recurrent topics in Normala Abd Latip's work include Computational Drug Discovery Methods (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and RNA Research and Splicing (3 papers). Normala Abd Latip is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and RNA Research and Splicing (3 papers). Normala Abd Latip collaborates with scholars based in Malaysia, United Kingdom and France. Normala Abd Latip's co-authors include Sarah P. Blagden, Hani Gabra, Martin Bushell, Eric O. Aboagye, Justin Weir, Manuela Mura, Anne E. Willis, Siti Hamimah Sheikh Abdul Kadir, Lee Carpenter and David M. Glover and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Normala Abd Latip

16 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Normala Abd Latip Malaysia 8 309 98 31 28 23 19 468
Jinyu Huang China 11 123 0.4× 52 0.5× 29 0.9× 13 0.5× 14 0.6× 21 277
Nina V. Stourman United States 11 295 1.0× 56 0.6× 37 1.2× 8 0.3× 17 0.7× 17 493
Antonio Strillacci Italy 13 376 1.2× 327 3.3× 56 1.8× 13 0.5× 10 0.4× 15 615
Joseph L. Jilek United States 14 357 1.2× 179 1.8× 81 2.6× 9 0.3× 6 0.3× 25 541
Linbo Zhang China 12 186 0.6× 69 0.7× 58 1.9× 5 0.2× 17 0.7× 20 442
Jung Ae Kang South Korea 12 202 0.7× 21 0.2× 44 1.4× 13 0.5× 9 0.4× 27 383
Xuemei Wen China 11 201 0.7× 22 0.2× 59 1.9× 16 0.6× 13 0.6× 18 401
Kang Cui China 11 242 0.8× 101 1.0× 75 2.4× 5 0.2× 15 0.7× 22 452
Ji Yang South Korea 10 187 0.6× 40 0.4× 91 2.9× 20 0.7× 5 0.2× 21 408
Qiaoli Shi China 10 199 0.6× 27 0.3× 32 1.0× 7 0.3× 6 0.3× 23 398

Countries citing papers authored by Normala Abd Latip

Since Specialization
Citations

This map shows the geographic impact of Normala Abd Latip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Normala Abd Latip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Normala Abd Latip more than expected).

Fields of papers citing papers by Normala Abd Latip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Normala Abd Latip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Normala Abd Latip. The network helps show where Normala Abd Latip may publish in the future.

Co-authorship network of co-authors of Normala Abd Latip

This figure shows the co-authorship network connecting the top 25 collaborators of Normala Abd Latip. A scholar is included among the top collaborators of Normala Abd Latip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Normala Abd Latip. Normala Abd Latip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Latip, Normala Abd, et al.. (2025). Comprehensive Review of CYP2B6 Transcriptional Modulators, Variants, and Their Role in Drug Interactions. Biomedical & Pharmacology Journal. 18(2). 1191–1207.
2.
Ab‐Rahim, Sharaniza, et al.. (2024). Association between polychlorinated biphenyl (PCB) and dioxin with metabolic syndrome (METS): a systematic review and meta-analysis. Scientific Reports. 14(1). 17941–17941. 4 indexed citations
3.
Latip, Normala Abd, et al.. (2023). Diketopiperazine and isoindolinone alkaloids from the endophytic fungus Aspergillus sp. HAB10R12. Phytochemistry. 211. 113685–113685. 5 indexed citations
4.
Anjani, Qonita Kurnia, et al.. (2022). Design and Development of Levodopa Loaded Polymeric Nanoparticles for Intranasal Delivery. Pharmaceuticals. 15(3). 370–370. 39 indexed citations
5.
Latip, Normala Abd, et al.. (2022). A Comprehensive Analysis of Human CYP3A4 Crystal Structures as a Potential Tool for Molecular Docking-Based Site of Metabolism and Enzyme Inhibition Studies. Journal of Computational Biophysics and Chemistry. 21(3). 259–285. 5 indexed citations
6.
Kadir, Siti Hamimah Sheikh Abdul, et al.. (2022). Are Vitamin E Supplementation Beneficial for Female Gynaecology Health and Diseases?. Molecules. 27(6). 1896–1896. 18 indexed citations
7.
Latip, Normala Abd, et al.. (2021). WRL-68 with the overexpression of CYP3A4 as an in vitro model to assess drug–drug interaction. Journal of Applied Pharmaceutical Science.
8.
9.
Kadir, Siti Hamimah Sheikh Abdul, et al.. (2021). Palm tocotrienol rich fraction with palm kernel oil supplementation prevents development of liver steatosis in high fat diet ICR mice. Translational Gastroenterology and Hepatology. 7. 2–2. 3 indexed citations
10.
Latip, Normala Abd, et al.. (2021). Revisiting CYP2C9-Mediated drug-drug Interactions: A Review. Research Journal of Pharmacy and Technology. 6166–6172. 4 indexed citations
11.
Latip, Normala Abd, et al.. (2021). Understanding the Impact of Perfluorinated Compounds on Cardiovascular Diseases and Their Risk Factors: A Meta-Analysis Study. International Journal of Environmental Research and Public Health. 18(16). 8345–8345. 20 indexed citations
12.
Latip, Normala Abd, et al.. (2020). Antagonistic Drug-herb Interactions between Clinacanthus nutans and Cyclophosphamide on WRL 68 Cell Line. SHILAP Revista de lepidopterología. 7(2). 2 indexed citations
13.
Latip, Normala Abd, et al.. (2019). Synergistic Interactions between Christia vespertilionis Leaves Extract and Chemotherapy Drug Cyclophosphamide on WRL-68 Cell Line. Asian Journal of Pharmaceutical Research and Development. 7(3). 109–113. 12 indexed citations
14.
Kadir, Siti Hamimah Sheikh Abdul, et al.. (2019). Palm Oil in Lipid-Based Formulations and Drug Delivery Systems. Biomolecules. 9(2). 64–64. 37 indexed citations
15.
Kadir, Siti Hamimah Sheikh Abdul, et al.. (2019). LOW CONCENTRATION OF BISPHENOL A INDUCES PROLIFERATION OF GASTRIC CANCER CELLS, HGC-27. Jurnal Teknologi. 81(6). 2 indexed citations
16.
Latip, Normala Abd, et al.. (2018). Drug-herb interaction between methanolic and aqueous extracts of Clinacanthus nutans and cisplatin on breast cancer cell line MCF-7. Frontiers in Pharmacology. 9. 1 indexed citations
17.
Mura, Manuela, Roni M. Lahr, Normala Abd Latip, et al.. (2015). The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer. Nucleic Acids Research. 44(3). 1227–1246. 113 indexed citations
18.
Mura, Manuela, T.G. Hopkins, Normala Abd Latip, et al.. (2014). LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression. Oncogene. 34(39). 5025–5036. 109 indexed citations
19.
Burrows, Carla, Normala Abd Latip, Lee Carpenter, et al.. (2010). The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration. Nucleic Acids Research. 38(16). 5542–5553. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinyu Huang Breakdown of academic impact, for papers by Nina V. Stourman Breakdown of academic impact, for papers by Antonio Strillacci Breakdown of academic impact, for papers by Joseph L. Jilek Breakdown of academic impact, for papers by Linbo Zhang Breakdown of academic impact, for papers by Jung Ae Kang Breakdown of academic impact, for papers by Xuemei Wen Breakdown of academic impact, for papers by Kang Cui Breakdown of academic impact, for papers by Ji Yang Breakdown of academic impact, for papers by Qiaoli Shi
Rankless by CCL
2026